Delivery Order SPE2DB25D3012-SPE2DB25FWYBG
Award Date 6/17/25
Potential Completion Date 7/10/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) valued at $10,662.57 under a firm fixed price contract. This delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX and valued at $999,999,999.00 through December 2026), represents a competitive, non-set-aside award with an ultimate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $42,650.28 for Tagrisso 80 mg tablets (30-count units) on September 24, 2025, with an ultimate completion date of October 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $31,987.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This competitive award, with no set-aside designation, reflects firm fixed-price pricing terms and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $10,641.07 to AmerisourceBergen Drug Corp for the supply of Tagrisso 40 mg tablets (30-count units) on November 7, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price, non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Tagrisso 80 mg tablets (30-count packages) valued at $10,662.57 under a Firm Fixed Price contract type. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, PA, was awarded a delivery order valued at $10,662.57 by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by May 12, 2025, and represents a continuation of the company's extensive pharmaceutical supply relationship with the federal government. The award was...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price arrangement with a ceiling value of $42,650.28 and an ultimate completion date of June 27, 2025. This non-set-aside, competitively awarded delivery order represents a continuation of the federal government's reliance on AmerisourceBergen as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) valued at $10,662.57. This firm fixed price delivery order, with an ultimate completion date of September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation. AmerisourceBergen,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Tagrisso 80 mg tablets in a quantity of 30 units. This Firm Fixed Price delivery order carries a ceiling value of $10,662.57 and is scheduled for completion by August 18, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on September 11, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price contract, classified as a non-set-aside competitive award, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's Conshohocken,...